Search by Products Line : Biogenetics LineFound 5 Product(s)
Gonapure® is a recombinant human follicle stimulating hormone (follitropin alpha) preparation of DNA origin. Gonapure® contains no luteinizing hormone (LH) activity.
Reiferon Retard is the 3rd Worldwide Novel Pegylated Hansenula-derived Recombinant Interferon alfa-2a for subcutaneous administration.
Thrombexx® cream: As an extension to Rhein-Minapharm's r-Hirudin portfolio, Thrombexx® 1120 I.U cream is introduced for the treatment of hematoma, thrombophlebitis and shunt thrombosis prophylaxis.
Thrombexx® Gel: As an extension to Rhein-Minapharm's r-Hirudin portfolio, Thrombexx® 1120 I.U gel is introduced for the treatment of hematoma, thrombophlebitis and shunt thrombosis prophylaxis.
Minapharm Pharmaceuticals receives regulatory approval from the Paul-Ehrlich Institute for a phase 1 multi-center clinical trial in Germany for its Adalimumab biosimilar
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement
for the Commercialization of Multiple Biosimilar Candidates of Alvotech
in the Middle East and Africa
As a global leader in biotechnology & cellular engineering, ProBioGen-Minapharm
As a continuation of Minapharm unique series of "Expert Panel",
The meeting was chaired by Prof. Abdel-Shakour EL MOHAMADY.
The First Netilmicin The Least Resistance
The First Netilmicin Combination the Quick Relief for Ocular Inflammation
Striking Glaucoma Treatment Goals Balancing EFFICACY, COMPLIANCE & AFFORADABILITY
Robust & long lasting correction of serum vitamin D levels For prophylaxis and/or treatment of vitamin D deficiency
Stay connected, subscribe to our newsletter for news and updates.